Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver

J Immunol. 2005 Feb 1;174(3):1549-56. doi: 10.4049/jimmunol.174.3.1549.

Abstract

IFN-alpha/beta-mediated functions promote production of MIP-1alpha (or CCL3) by mediating the recruitment of MIP-1alpha-producing macrophages to the liver during early infection with murine CMV. These responses are essential for induction of NK cell inflammation and IFN-gamma delivery to support effective control of local infection. Nevertheless, it remains to be established if additional chemokine functions are regulated by IFN-alpha/beta and/or play intermediary roles in supporting macrophage trafficking. The chemokine MCP-1 (or CCL2) plays a distinctive role in the recruitment of macrophages by predominantly stimulating the CCR2 chemokine receptor. Here, we examine the roles of MCP-1 and CCR2 during murine CMV infection in liver. MCP-1 production preceded that of MIP-1alpha during infection and was dependent on IFN-alpha/beta effects for induction. Resident F4/80(+) liver leukocytes were identified as primary IFN-alpha/beta responders and major producers of MCP-1. Moreover, MCP-1 deficiency was associated with a dramatic reduction in the accumulation of macrophages and NK cells, as well as decreased production of MIP-1alpha and IFN-gamma in liver. These responses were also markedly impaired in mice with a targeted disruption of CCR2. Furthermore, MCP-1- and CCR2-deficient mice exhibited increased viral titers and elevated expression of the liver enzyme alanine aminotransferase in serum. These mice also had widespread virus-induced liver pathology and succumbed to infection. Collectively, these results establish MCP-1 and CCR2 interactions as factors promoting early liver inflammatory responses and define a mechanism for innate cytokines in regulation of chemokine functions critical for effective localized antiviral defenses.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Movement / genetics
  • Cell Movement / immunology
  • Chemokine CCL2 / biosynthesis
  • Chemokine CCL2 / deficiency
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / physiology*
  • Chemokine CCL3
  • Chemokine CCL4
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / immunology*
  • Cytomegalovirus Infections / pathology
  • Cytomegalovirus Infections / virology
  • Female
  • Humans
  • Immunity, Innate
  • Inflammation / immunology
  • Inflammation / virology
  • Interferon Type I / administration & dosage
  • Interferon Type I / physiology*
  • Interferon Type I / therapeutic use
  • Kinetics
  • Liver / immunology*
  • Liver / metabolism
  • Liver / pathology*
  • Liver / virology
  • Macrophage Inflammatory Proteins / biosynthesis
  • Macrophage Inflammatory Proteins / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muromegalovirus / immunology
  • Receptors, CCR2
  • Receptors, Chemokine / biosynthesis
  • Receptors, Chemokine / deficiency
  • Receptors, Chemokine / genetics
  • Receptors, Chemokine / physiology*
  • Recombinant Proteins
  • Viral Load

Substances

  • CCR2 protein, human
  • Ccl2 protein, mouse
  • Ccr2 protein, mouse
  • Chemokine CCL2
  • Chemokine CCL3
  • Chemokine CCL4
  • Cytokines
  • Interferon Type I
  • Macrophage Inflammatory Proteins
  • Receptors, CCR2
  • Receptors, Chemokine
  • Recombinant Proteins